A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-1)
A double-blind, randomized, vehicle-controlled clinical multi-center study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 2 and 5%, applied once daily for 12 weeks in patients with facial acne vulgaris - GEDACNE
AN OPEN LABEL CLINICAL STUDY TO EVALUATE THE LONG-TERM DERMAL SAFETY PROFILE OF 12-WEEKS TOPICAL ADMINISTRATION OF N-ACETYL-GED-0507-34-LEVO GEL 5% IN PATIENTS WITH FACIAL ACNE - NAC-GED-0507 GEL 5% IN ACNE
100 项与 SM2 Software & Services Management SA 相关的临床结果
0 项与 SM2 Software & Services Management SA 相关的专利(医药)
100 项与 SM2 Software & Services Management SA 相关的药物交易
100 项与 SM2 Software & Services Management SA 相关的转化医学